Cerezyme sanofi genzyme?

What is Cerezyme, and how is it related to Sanofi Genzyme?

Cerezyme is the brand name for imiglucerase, an enzyme replacement therapy used to treat Gaucher disease (a lysosomal storage disorder). The product has been marketed under Sanofi Genzyme. [1]

Who makes Cerezyme today—Sanofi or a different company?

Cerezyme is associated with Sanofi Genzyme as the manufacturer/marketer of record for the product. [1]

What is Cerezyme used for?

Cerezyme (imiglucerase) is used to treat Gaucher disease. [1]

Is Cerezyme the same as other Gaucher enzyme therapies?

Cerezyme is the imiglucerase therapy brand. Other Gaucher treatments may use different enzyme forms or brands, but Cerezyme specifically refers to imiglucerase under the Sanofi Genzyme offering. [1]

What patients usually look up next: dosing, side effects, and monitoring

People searching for Cerezyme often next look for information on how it’s given (infusion/route), typical monitoring, and adverse effects. Those details depend on the specific Gaucher disease type and patient factors, and they are typically covered in the prescribing information for the Sanofi Genzyme product. [1]

Sources

1. https://www.sanofi.com/en/products/rare-diseases/cerezyme